SCHEMBL4978302

SCHEMBL4978302

O=C(O)CCCC(=O)NC(=O)NO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 1/20 0.50
FOLH1 Q04609 3/20 0.46
KDM4E B2RXH2 1/20 0.46
KDM6B O15054 1/20 0.46
KDM5C P41229 1/20 0.46
EGLN1 Q9GZT9 1/20 0.46
PHF8 Q9UPP1 1/20 0.46
KDM2A Q9Y2K7 1/20 0.46
LMNA P02545 2/20 0.43
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
TSHR P16473 2/20 0.42
NFKB1 P19838 1/20 0.42
PMP22 Q01453 1/20 0.42
PRMT1 Q99873 1/20 0.40
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4975915 0.88 SLC22A6 (0.58) SLC22A6FOLH1KDM4EKDM6BKDM5C
SCHEMBL4980094 0.86 PHF8 (0.64) FOLH1KDM4EKDM6BKDM5CEGLN1
SCHEMBL1261013 0.80 FOLH1 (0.70) SLC22A6FOLH1KDM4EKDM6BKDM5C
SCHEMBL4976329 0.78 SLC22A6 (0.46) SLC22A6FOLH1KDM4EKDM6BKDM5C
SCHEMBL4979704 0.78 SLC22A6 (0.46) SLC22A6FOLH1KDM4EKDM6BKDM5C
SCHEMBL17828357 0.76 LMNA (0.48) SLC22A6FOLH1LMNATSHRNFKB1
SCHEMBL2813242 0.75 HDAC1 (0.74) SLC22A6FOLH1KDM4EKDM6BKDM5C
SCHEMBL4980899 0.74 SLC22A6 (0.52) SLC22A6FOLH1KDM4EKDM6BKDM5C
SCHEMBL4977573 0.74 SLC22A6 (0.52) SLC22A6KDM4ELMNATSHRNFKB1
SCHEMBL12967769 0.74 SLC22A6 (0.52) SLC22A6FOLH1KDM4EKDM6BKDM5C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1685114-B1 ANTIBACTERIAL AND/OR ANTIPROTOZOAL NITROIMIDAZOLE DERIVATIVE COMPOUNDS WITH UREASE INHIBITOR ACTIVITY, PROCESS FOR PREPARING THESE COMPOUNDS AND USE IN PHARMACEUTICAL COMPOSITIONS AND MEDICINES. EMS SA (BR) 2008-10-15 EP claimed